ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 37 filers reported holding ASCENDIS PHARMA A/S in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $15,653,000 | +30.1% | 559,035 | -5.9% | 0.01% | +30.0% |
| Q4 2016 | $12,029,000 | -7.6% | 594,295 | -8.3% | 0.01% | -9.1% |
| Q3 2016 | $13,025,000 | +48.1% | 647,997 | -2.2% | 0.01% | +57.1% |
| Q2 2016 | $8,797,000 | -29.2% | 662,894 | -1.1% | 0.01% | -36.4% |
| Q1 2016 | $12,429,000 | -3.3% | 670,007 | -4.5% | 0.01% | 0.0% |
| Q4 2015 | $12,859,000 | -49.2% | 701,916 | -50.9% | 0.01% | 0.0% |
| Q3 2015 | $25,302,000 | – | 1,429,526 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |